1. Home
  2. ASND vs LBTYA Comparison

ASND vs LBTYA Comparison

Compare ASND & LBTYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASND
  • LBTYA
  • Stock Information
  • Founded
  • ASND 2006
  • LBTYA 2004
  • Country
  • ASND Denmark
  • LBTYA Bermuda
  • Employees
  • ASND N/A
  • LBTYA N/A
  • Industry
  • ASND Biotechnology: Pharmaceutical Preparations
  • LBTYA Cable & Other Pay Television Services
  • Sector
  • ASND Health Care
  • LBTYA Telecommunications
  • Exchange
  • ASND Nasdaq
  • LBTYA Nasdaq
  • Market Cap
  • ASND 7.3B
  • LBTYA 7.5B
  • IPO Year
  • ASND 2015
  • LBTYA N/A
  • Fundamental
  • Price
  • ASND $126.51
  • LBTYA $12.22
  • Analyst Decision
  • ASND Strong Buy
  • LBTYA Buy
  • Analyst Count
  • ASND 13
  • LBTYA 8
  • Target Price
  • ASND $191.77
  • LBTYA $25.50
  • AVG Volume (30 Days)
  • ASND 422.4K
  • LBTYA 2.6M
  • Earning Date
  • ASND 11-14-2024
  • LBTYA 10-29-2024
  • Dividend Yield
  • ASND N/A
  • LBTYA N/A
  • EPS Growth
  • ASND N/A
  • LBTYA N/A
  • EPS
  • ASND N/A
  • LBTYA N/A
  • Revenue
  • ASND $365,187,374.00
  • LBTYA $7,674,500,000.00
  • Revenue This Year
  • ASND $10.30
  • LBTYA $0.23
  • Revenue Next Year
  • ASND $90.02
  • LBTYA $0.93
  • P/E Ratio
  • ASND N/A
  • LBTYA N/A
  • Revenue Growth
  • ASND 115.54
  • LBTYA 3.53
  • 52 Week Low
  • ASND $90.13
  • LBTYA $10.93
  • 52 Week High
  • ASND $161.00
  • LBTYA $21.56
  • Technical
  • Relative Strength Index (RSI)
  • ASND 46.41
  • LBTYA 18.25
  • Support Level
  • ASND $124.11
  • LBTYA $10.93
  • Resistance Level
  • ASND $129.86
  • LBTYA $12.63
  • Average True Range (ATR)
  • ASND 5.50
  • LBTYA 0.62
  • MACD
  • ASND 0.28
  • LBTYA -0.95
  • Stochastic Oscillator
  • ASND 56.59
  • LBTYA 12.89

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

About LBTYA Liberty Global Ltd.

Liberty Global is a holding company with interests in several telecom companies in the U.K., Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

Share on Social Networks: